Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Recombinant Anti-Insulin Receptor alpha (Clone 83-14)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Bovine, Human, Sheep, Pig |
| Conjugation | Unconjugated |
Recombinant Anti-Insulin Receptor alpha (Clone 83-14)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Bovine, Human, Sheep, Pig |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-18 (Clone 125-2H)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-p53 (Clone PAb421)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rabbit, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-p53 (Clone PAb421)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rabbit, Rat |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B6)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Notch 2 (Clone B9)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
| Conjugation | Unconjugated |
Recombinant Anti-Flavivirus group antigen (Clone D1-4G2-4-15 (4G2))
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Dengue virus, West Nile Virus, Yellow Fever Virus |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-IL-2 (Clone LNKB-2)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-2 (Clone LNKB-2)
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-SNAP-25 (Clone SP12)
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Feline, Guinea Pig, Hamster, Human, Mouse, Rat, Pig, Cow |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Rhodopsin (Clone Rho 1D4)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Zebrafish, Cow |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Rhodopsin (Clone Rho 1D4)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat, Zebrafish, Cow |
| Conjugation | Unconjugated |
Recombinant Anti-Glucose-dependent insulinotropic Receptor (Clone Gipg013)
| Applications | Bl, ELISA, IF |
| Reactivities | Human, Mouse, Rat, Dog |
| Conjugation | Unconjugated |
| Modifications | This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Applications
- IF
Assay Types
- Indirect
Filter by
Category
Target Symbol
- H3C1 (19)
- CCR5 (8)
- N (8)
- EGFR (5)
- S (5)
- H4-16 (4)
- NOTCH2 (4)
- TIMD4 (4)
- TNFRSF8 (4)
- CD44 (3)
- ITGA5 (3)
- TNF (3)
- TYRP1 (3)
- ADRB2 (2)
- AGER (2)
- ARHGAP22 (2)
- CD163 (2)
- CD74 (2)
- CD81 (2)
- CMKLR1 (2)
- CR1 (2)
- EPHA2 (2)
- FCGR2A (2)
- GPR119 (2)
- GROUP ANTIGEN (2)
- H3 (2)
- H4 (2)
- IL10 (2)
- IL18 (2)
- IL2 (2)
- IL2RA (2)
- INSR (2)
- ITGA2B (2)
- ITGB2 (2)
- MUC1 (2)
- NCAM1 (2)
- RHO (2)
- SLC3A2 (2)
- SNAP25 (2)
- TP53 (2)
- TSPAN1 (2)
- AKT1 (1)
- ASH2L (1)
- AURKB (1)
- BRD4 (1)
- CBX1 (1)
- CBX2 (1)
- DNMT3B (1)
- FOXP1 (1)
- FOXP4 (1)
- H2AZ1 (1)
- HIST2H3C (1)
- KDM1A (1)
- KDM4B (1)
- L3MBTL1 (1)
- PRDM4 (1)
- PRDM9 (1)
- PRMT5 (1)
- SETD7 (1)
- STAT5A (1)
- TDRD3 (1)
- TNFSF13B (1)
- WDR5 (1)
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)